The update comes about six weeks after an early alert flagged reports of 120 injuries and one death linked to reprocessing of the device. CEO Scott Whitaker said “an exemption was provided for most ...
Tazbaz was director of the FDA’s Digital Health Center of Excellence for two years, leading key policies on artificial intelligence and software as a medical device.